On June 18, 2018, the International Scientific School and Conference on “Innovative Technologies in Clinical Immunology: From Immunodiagnostics to Personalized Targeted Immunotherapy and Immunorehabilitation” was held at Tbilisi State Medical University. The School-Conference speakers were invited from the United States, Israel and Spain. Two of them - Giorgi Guruli and Manana Kvezereli are graduates of Tbilisi State Medical University.

Georgi Guruli - Division of Urology, Virginia Commonwealth University, School of Medicine, Richmond, USA – “Trafficking of dendritic cells in tumor-bearing mouse”.

Michael Shurin – Division of Clinical Immunopathology, University of Pittsburgh Medical Center, Pittsburgh, USA – “Pharmacological targeting of the tumor immunoenvironment: chemomodulation, chemoresistance and chemonanodelivery”.

Manana Kvezereli-Javey – Department of Oncology Diagnostics, Cell Max Life laboratories, San Francisco, USA – “Hope, hype and reality of liquid biopsy”.

Natalia Aptsiauri - Department of Biochemistry, Molecular Biology and Immunology, Medical School, University of Granada, Spain – “Tumor heterogeneity and biomarkers: genomic and immunological aspects”.

Eliyahu Magen – Department of Medicine, Clinical Immunology and Allergy Division, Barzilai University Medical Center, Ashkelon, Israel – “CAR T cells: Engineering patients’ immune cells to treat their cancers”.

Ketevan Gendzekhadze – Department og Hematopoietic stem cell transplantation, City of Hope, National Medical Center, Duarte, California, USA – “Genetic chimera: post-transplant donor DNA quantification methodology”.

Michael R. Shurin – Division of Clinical Immunopathology, University of Pittsburgh Medical Center, Pittsburgh, USA – Nanomaterials in cancer: friends or foes?